The impact of substance use at psychosis onset on First Episode Psychosis course: Results from a 1 year follow-up study in Bologna

Schizophrenia Research

Volumn 153, Issue 1-3, 2014, Pages 60-63

  Tarricone, Ilaria ^a,b,c   Boydell, Jane ^c   Panigada, Serena ^a   Allegri, Fabio ^a   Marcacci, Thomas ^a   Minenna, Maria Gabriella ^b   Kokona, Arnisa ^a   Triolo, Federico ^a   Storbini, Viviana ^a   Michetti, Rossella ^b   Morgan, Craig ^c   Di Forti, Marta ^c   Murray, Robin M ^c   Berardi, Domenico ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Azienda USL di Bologna   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

First episode psychosis; Psychosis course; Substance use

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SUBSTANCE USE; ANALYSIS OF VARIANCE; COMMUNITY MENTAL HEALTH CENTER; NONPARAMETRIC TEST; PSYCHOTIC DISORDERS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADULT; AGE OF ONSET; ANALYSIS OF VARIANCE; COHORT STUDIES; COMMUNITY MENTAL HEALTH CENTERS; FEMALE; HUMANS; ITALY; MALE; PSYCHOTIC DISORDERS; STATISTICS, NONPARAMETRIC; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84895793349     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.01.014     Document Type: Article

References (20)

1. Addington D.E., Beck C., Wang J., Adams B., Pryce C., Zhu H., Kang J., McKenzie E. Predictors of admission in first-episode psychosis: developing a risk adjustment model for service comparisons. Psychiatr. Serv. 2010, 61(5):483-488.
2. Arsenault L., Cannon M., Poulton R., Murray R., Caspi A. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002, 325:1212-1213.
3. Barkus E.J., Stirling J., Hopkins R.S., Lewis S. Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 2006, 39:175-178.
4. Bebbington P.E., Craig T., Garety P., Fowler D., Dunn G., Colbert S., et al. Remission and relapse in psychosis: operational definitions based on case-note data. Psychol. Med. 2006, 36:1551-1562.
5. Bertani M., Lasalvia A., Bonetto C. The influence of gender on clinical and social characteristics of patients at psychosis onset: a report from the Psychosis Incident Cohort Outcome Study (PICOS). Psychol. Med. 2012, 42:769-780.
6. Boydell J., Bebbington P., Bhavsar V. Unemployment, ethnicity and psychosis. Acta Psychiatr. Scand. 2013, 127:202-209.
7. Ceskova E., Prikryl R., Kasparek T. Outcome in males with first-episode schizophrenia: 7-year follow-up. World J. Biol. Psychiatry 2011, 12:66-72.
8. Chang W.C., Tang J.Y., Hui C.L. Gender differences in patients presenting with first-episode psychosis in Hong Kong: a three-year follow up study. Aust. N. Z. J. Psychiatry 2011, 45:199-205.
9. Crebbin K., Mitford E., Paxton R., Turkington D. First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group. Soc. Psychiatry Psychiatr. Epidemiol. 2009, 44:710-715.
10. Di Forti M., Morgan C., Dazzan P. High-potency cannabis and the risk of psychosis. Br. J. Psychiatry 2009, 195:488-491.
11. Di Forti M., Sallis H., Allegri F., Trotta A., Ferraro L., Stilo A.S., Marconi A., La Cascia C., Reis-Menques T., Pariante C., Dazzan P., Mondelli V., Paparelli A., Kolliakou A., Prata D., Gaugrhan F., David A.S., Morgan C., Sthal D., Khondoker M., MacCabe J.H., Murray R.M. Daily use, especially of high potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr. Bull. 2014, (in press).
12. Jablensky A., Sartorius N., Ernberg G., Anker M., Korten A., Cooper J.E., Day R., Bertelsen A. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol. Med. Monogr. Suppl. 1992, 20:1-97.
13. Jobe T.H., Harrow M. Long-term outcome of patients with schizophrenia: a review. Can. J. Psychiatry 2005, 50:892-900.
14. Malla A.K., Norman R., Bechard-Evans L., Schmitz N., Manchanda R., Cassidy C. Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service. Psychol. Med. 2008, 38(11):1585-1593.
15. Miller R., Ream G., McCormack J., Gunduz-Bruce H., Sevy S., Robinson D. A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophr. Res. 2009, 113:138-144.
16. Selten J.P., Veen N.D., Hoek H.W., Laan W., Schols D., van der Tweel I., Feller W., Kahn R.S. Early course of schizophrenia in a representative Dutch incidence cohort. Schizophr. Res. 2007, 97(1-3):79-87.
17. Singh S.P., Croudace T., Amin S. Three-year outcome of first-episode psychoses in an established community psychiatric service. Br. J. Psychiatry 2000, 176:210-216.
18. Tarricone I., Mimmi S., Paparelli A. First-episode psychosis at the West Bologna Community Mental Health Centre: results of an 8-year prospective study. Psychol. Med. 2012, 7:1-10.
19. Van Os J., Kapur S. Schizophrenia. Lancet 2009, 374:635-645.
20. Van Os J., Bak M., Hanssen M., Bijl R.V. Cannabis use and psychosis: a longitudinal population-based study. Epidemiol. Rev. 2002, 156:319-327.